Th1 to Th2 cytokine shifts in nonobese diabetic mice: Sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation

Journal of Immunology

Volumn 166, Issue 2, 2001, Pages 1352-1359

  Serreze, D V ^a   Chapman, H D ^a   Post, C M ^a   Johnson, E A ^a   Suarez Pinzon, W L ^a   Rabinovitch, A ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL COMPARTMENTALIZATION; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE RESISTANCE; IMMUNOSTIMULATION; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OUTCOMES RESEARCH; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

EID: 0035863721     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.2.1352     Document Type: Article

References (44)

1. The identity and ontogenic origins of autoreactive T lymphocytes in NOD mice
2. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: Therapeutic intervention by immunostimulation?
3. Insulin-dependent diabetes mellitus
4. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
5. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model
6. Differential ability of T cell subsets to undergo activation-induced cell death
7. Unequal death in T helper (Th)1 and Th2 effectors: TH1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis
8. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hematopoietic origin, but not on thymic epithelium
9. Hematopoietic/stem cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: Defective regulation of cytokine receptors and protein kinase C
10. g7 molecules from non-obese diabetic mice are pool peptide binders
11. Breaking self-tolerance in nonobese diabetic mice
12. Splenic macrophages from the NOD mouse are defective in ability to present antigen
13. Distinction between antigenicity and tolerogenicity among HBcAg T cell determinants: Influence of peptide-MHC interaction
14. Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death
15. Limits to the differential avidity model of T cell selection in the thymus
16. + β islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice
17. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice
18. Inhibition of diabetes by an insulin reactive CD4 T-cell clone in the nonobese diabetic mouse
19. Induction of diabetes in nonobese diabetic mice by Th2 T cell clones from a TCR transgenic mouse
20. Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice
21. Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-γ receptor loci
22. Interferon-γ receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice
23. Thymic T cell proliferative unresponsiveness in autoimmune NOD mice. II. IL-4 reverses NOD thymic T cell energy and prevents the onset of diabetes
24. IL-4 prevents insulitis and insulin dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function
25. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse
26. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
27. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice
28. Multiple defects of immune cell function in mice with disrupted interferon-γ genes
29. Generation and analysis of interleukin-4 deficient mice
30. Interleukin-10-deficient mice develop chronic enterocolitis
31. null mice
32. Induction of GAD65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope-dependent
33. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice
34. Intrathymic islet cell transplantation reduces β-cell antoimmunity and prevents diabetes in NOD/Lt mice
35. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmane diabetes in nonobese diabetic mice
36. Defective activation of T suppressor cell function in nonobese diabetic mice: Potential relation to cytokine deficiencies
37. a donors
38. Interleukin-4 deficiency does not exacerbate disease in NOD mice
39. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes
40. Regulation of immune responses by TGF-β
41. Evidence of positive cross-regulation on Th1 by Th2 and antigen presenting cells: Effects on Th1 induced by IL-4 and IL-12
42. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-β1
43. TGF-β1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice
44. TGF-β1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype